Universiti Teknologi Brunei ranks among top tech universities in Asean
UTB is also committed to producing outstanding talent for a sustainable, global and enterprising society rooted in the Malay Islamic Monarchy (MIB) national philosophy to help achieve Brunei Vision 2035.
UTB's commitment to achieving Brunei Vision 2035 was highlighted by the university's Vice-Chancellor Datin Paduka Professor Dr Zohrah Sulaiman (pic), in her remarks as the guest of honour at the UTB-MIC Computing Degree Programmes and BriCOMP certificate presentation ceremony on Thursday (July 18).
She highlighted that UTB is ranked among the top nine technology and engineering universities in Asean by the Quacquarelli Symonds (QS) World University Rankings 2026.
The university also debuted in the prestigious Times Higher Education (THE) World University Rankings 2025, securing a position among the top 801-1000 institutions worldwide and ranking among the 23 universities in Asean.
She described this as an impressive accomplishment that reflects UTB's strong focus on academic excellence and innovation.
The vice-chancellor also shared a list of the top 15 highest-paying jobs in the world for 2025, which included artificial intelligence (AI)/machine learning engineer at number three, data scientist at number four, blockchain developer at number five, investment banker at number seven, cybersecurity specialist at number eight, cloud engineer at number 10, marketing manager at number 11 and management consultant at number 14.
She explained that 'tech-centric growth fields like AI, cloud computing, and cybersecurity dominate. You may be wondering whether the ones listed above apply to the global markets. They do, and it means that UTB and MIC are preparing you for the world.'
She continued, 'We are proud of our accredited programmes. The School of Computing and Informatics has attained accreditation from the British Computer Society (BCS) for all its undergraduate programmes, as well as dual partial accreditation for our Master of Science (By Coursework) in Computing and Information Systems.'
BCS accreditation, she added, 'is recognised in more than 200 countries, which means you can work anywhere with a BCS-certified degree.'
She also highlighted that the UTB School of Business' undergraduate programmes are accredited by the European Foundation for Management Development (EFMD).
EFMD accreditation indicates that a business school has met the organisation's rigorous standards for teaching and research quality, and that its degrees are recognised as credible by employers and other stakeholders.
In addition, she said, 'UTB also offers modules to develop soft skills, such as effective communication, entrepreneurship, and ethics.'
The university also has facilities to support a passion for information technology, AI and machine learning.
'The Huawei Academy provides industrial training on-site, and the Artificial Intelligence and Machine Learning (AiML) Hub is an innovation hub that supports AI talent through education, training, research, and innovation.' – Borneo Bulletin/ANN
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
4 days ago
- The Star
New ESG association to drive sustainability practices
SEAM vice-president Alex Yeoh (left) and founding president Liang Yit Wen KUALA LUMPUR: The Sustainability & ESG Association Malaysia (SEAM) had its soft launch today with the aim to drive meaningful environmental, social, and governance (ESG) adoption through real-world implementation. According to the association's statement, its cornerstone is the IDEA-C Framework – a structured approach designed to help corporates identify ESG opportunities, diagnose gaps, engineer solutions, activate change, and communicate measurable impact. "SEAM fills a critical market gap by connecting ESG-certified professionals and solution providers with businesses seeking verified, scalable sustainability practices," it said. SEAM's membership is open to ESG-certified professionals, consultants, implementors, compliant corporates, and relevant institutional alliances. The association will also work closely with stakeholders such as regulators, certification bodies, and capital market players. "We provide a trusted, neutral platform that brings both sides together, helping businesses take action confidently, and enabling solution providers to scale their impact. "Our aim is to turn ESG from ambition into execution, and from pledges into measurable value," said SEAM founding president Liang Yit Wen.
Malaysian Reserve
4 days ago
- Malaysian Reserve
Nelson-Jameson Distribution Center Earns 100% Score On Its First Safe Quality Food Audit
The Jerome, Idaho facility is the latest distribution center location to achieve the SQF Institute's top global food safety and quality certification MARSHFIELD, Wis, July 23, 2025 /PRNewswire/ — Nelson-Jameson, a leading distributor in the food processing industry, has announced that its Jerome, Idaho strategic distribution center has earned a 100% score in its first Safe Quality Food (SQF) audit. An SQF-certified site indicates a company's commitment to providing quality products that are safely received, handled, stored, and delivered. A 100% score represents the highest level of food safety and food quality. The 100% perfect rating comes in the first audit of the Jerome strategic distribution center, which opened in 2024. This perfect score is the fourth straight for Nelson-Jameson in the past year across all distribution centers. 'Our Jerome distribution center earning a perfect SQF certification illustrates that our dedication to food safety is a throughline in everything we do in every facility we have,' says Mike Rindy, President of Nelson-Jameson. 'We take pride in our distribution center having achieved this perfect score during the audits, and in our team's commitment to maintaining food and worker safety every day.' The SQF program motto is: 'Say what you do, do what you say.' SQF has a code for each company to follow, and each individual company writes its policies and procedures based on the code. Maintaining these procedures is a continuous process, as documentation must be reviewed, monitored, verified, and validated throughout the year. The Eagle Certification Group, an independent certification company authorized by the SQF Institute, conducts the audits in adherence to the globally acknowledged industry standards set by SQF. Learn more about the SQF program at Nelson-Jameson is a fourth-generation, family-owned distributor to the food processing industry. From the company's roots in dairy production supplies, it has expanded to offer a broad range of food processing products and services that help food and beverage organizations operate efficiently with the highest quality, food safety, and compliance standards. The company represents more than 1,000 vendors, distributes more than 79,000 curated products, and employs more than 300 people nationwide. The food processing industry leader also operates NEXT Logistics, a transportation arm that provides delivery services from its Wisconsin, California, Idaho, Pennsylvania, and Texas strategic distribution centers. Since 1947, Nelson-Jameson has supported food, beverage, and dairy processors with innovative products and a comprehensive set of solutions that keep pace with changing consumer tastes, manufacturing processes, and distribution channels. The company values delivering the exceptional for its customers by leading with the guiding principles of kindness and mutual respect. Nelson-Jameson is a supplier of choice for customers in all 50 states and international markets. For more information, please visit
Focus Malaysia
5 days ago
- Focus Malaysia
Southeast Asia pharma market set to outgrow global average
SOUTHASIA Asia (SEA) presents a substantial future prospect for the pharmaceutical market. Its projected growth rate significantly outpaces the global average and other major established markets. As of calendar year 2024 (CY24), global total market size for pharmaceuticals is estimated at USD1.5 tri. In comparison, SEA's total market size is estimated at USD27 bil. The significant growth for SEA indicates that ASEAN is a prime growth engine for the global pharmaceutical industry. This makes it an attractive destination for investment and market expansion. The Philippines and Malaysia show steady growth in a biosimilar export potential, reaching USD 111 mil and USD 70 mil respectively by 2027. Malaysia's growth, though robust, is relatively smaller in absolute terms compared to Thailand, Vietnam, and Indonesia. However, companies like Duopharma and Pharmaniaga are actively developing Halal-certified biosimilars. Overall, biosimilars is an untapped potential due to increasing healthcare demands and cost pressure. 'We believe that investing in local manufacturing of biosimilars can open avenues for SEA countries to export,' said MBSB Research. Countries that prioritise and invest in local biosimilar production are likely to become stronger exporters in this field. This aligns with the broader trends of high pharmaceutical market growth in SEA driven by demographics, NCDs, and the increasing sophistication of healthcare systems, all of which necessitate tailored and creative market strategies. Malaysia's pharmaceutical sector boasts a strong and strategically recognized local manufacturing base that significantly contributes to medicine security, especially for generics and essential medicines. While Malaysia demonstrates capabilities in exporting to highly regulated markets like the USA, it remains heavily reliant on imports for patented drugs, biologics, vaccines, and key APIs. The main challenge for Malaysia lies in bridging this gap by further boosting local R&D, attracting more sophisticated manufacturing capabilities, and strengthening its position in the global pharmaceutical value chain beyond just generics. 79% of total volume of generic medicines and 47% of items listed in National Essential Medicines List (NEML) are locally produced. However, most drugs, notably patented medicaments, immunoglobulins, human vaccines and insulins, are still dependent on imports. Malaysia consistently shows widening trade deficit underscores Malaysia's high reliance on imported pharmaceuticals. While local production is strong in generics, the country still depends heavily on foreign sources for innovative, patented, and specialised medicines. This reinforces the government's strategic focus on local manufacturing and technology transfer to enhance medicine security and reduce import dependency in the long run. The overall trend in the regional and local pharmaceutical market suggests that both domestic and foreign investors will see growing opportunities in Malaysia. The 51% FDI / 49% DDI ratio suggests a healthy balance between local commitment, and global capital and expertise. FDI indicates that Malaysia is highly attractive to foreign pharmaceutical companies, bringing in capital, technology, and global best practices, while DDI signifies robust local entrepreneurship and investment from Malaysian companies, demonstrating confidence in the domestic market and capabilities. We opine that the untapped drug manufacturing ecosystem will continue to follow the megatrend of new innovative drugs – including biologics, biosimilars and cell & gene therapy drugs – and open more opportunities for Malaysia to be a major healthcare hub in the region. While direct pharmaceutical exports from Malaysia to the US might face immediate headwinds from tariffs, the broader impact on Malaysia's healthcare subsector could come from indirect effects on global pharmaceutical supply chains and procurement costs. This would affect the affordability and availability of medicines within Malaysia for all citizens and healthcare providers. The Malaysian government and industry players are already responding by prioritizing supply chain diversification and exploring domestic production enhancements to mitigate these risks. Meanwhile, we believe a multi-pronged approach involving government action, industry adaptation, and consumer awareness will be crucial. Overall, we maintain positive on the healthcare sector. The pharmaceutical market is fundamentally driven by robust demographic trends, which naturally increases the demand for healthcare services and medicines. —July 23, 2025 Main image: Daily Sabah
